Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
3
×
financing
3
×
life sciences
national blog main
startups
3
×
venture capital
boston
boston top stories
funding
20/20 healthcare partners
accent therapeutics
aducanumab
akero therapeutics
alzheimer's disease
amblyotech
amgen ventures
amyotrophic lateral sclerosis
anthony despasqua
apellis pharmaceuticals
aragon pharmaceuticals
asklepios biopharmaceutical
bioeurope
biogen
biomarin pharmaceutical
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
cancer
cara therapeutics
christian angermayer
corey goodman
deerfield management
detroit blog main
detroit top stories
dolby family ventures
drug development
drug discovery
enclear therapies
What
new
3
×
activity
approach
approvals
associated
bags
bio
biogen
biotechs
capital
clamped
companies
covid
delays
develop
developing
device
dialysis
disease
diseases
drugs
economic
enclear
fast
fda
harmful
including
investing
investors
ipo
isn’t
led
limited
lot
making
medicine
medicines
mitigated
nets
neuro
Language
unset
Current search:
new
×
startups
×
" boston blog main "
×
financing
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device